Switch to:
More From Other Websites
Grifols, S.A. upgraded by JP Morgan Jan 03 2017
Hologic (HOLX) to Divest Blood Screening Business to Grifols Dec 19 2016
Hologic Still A Buy After Getting 'Lofty' Price For Blood-Screening Unit Dec 15 2016
Hologic Agrees to Sell Blood Screening Business to Grifols for $1.85B Dec 14 2016
Grifols to buy Hologic's stake in blood screening JV for $1.85 billion Dec 14 2016
Hologic to sell stake in blood screening unit for $1.85 bln Dec 14 2016
Grifols agrees to acquire Hologic's share of NAT donor screening unit for USD 1,850 million Dec 14 2016
Hologic to Divest Blood Screening Business to Partner Grifols for $1.85 Billion Dec 14 2016
ETFs with exposure to Grifols SA : December 13, 2016 Dec 13 2016
Virgin America Inc (VA): Is It Right For Your Portfolio? Dec 09 2016
Ligand Pharmaceuticals Inc. (LGND): Hedge Fund Sentiment Unchanged Dec 05 2016
ETFs with exposure to Grifols SA : December 2, 2016 Dec 02 2016
John Paulson's Largest 3rd Quarter Trades Dec 01 2016
What Explains the Huge Jump in Louisiana-Pacific Corporation (LPX)’s Hedge Fund Ownership? Nov 25 2016
Grifols SA :GRFS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016 Nov 11 2016
Sales of the Bioscience Division grow by +6.5%, increasing Grifols’ revenues to EUR 2,952 million... Nov 08 2016
Sales of the Bioscience Division grow by +6.5%, increasing Grifols' revenues to EUR 2,952 million Nov 08 2016
The CLIA Lab at the Grifols Immunohematology Center Will Now Offer Both Serology and Molecular Tests Oct 20 2016
The CLIA Lab at the Grifols Immunohematology Center Will Now Offer Both Serology and Molecular Tests Oct 20 2016
Grifols relocates its headquarters in Germany to a new office building Oct 13 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK